News & Updates

Cancer treatment personalization with biomarkers: What lies ahead?

Sarcopenia plus obesity a greater risk factor for frailty, functional decline

The presence of both sarcopenia and obesity compounds the risks of frailty, functional decline, cognitive impairment, and mobility limitations compared with either condition alone, according to a study from Singapore.

Childhood obesity may affect penis size

Obesity during childhood appears to have an impact on penile growth, while obesity in adulthood influences the appearance of the penis rather than its actual size, reveals a study.

Mindfulness may improve daily sexual function

Mindfulness helps promote present-moment awareness in daily sexual interaction, which potentially boosts sexual function, according to a study.

Midline extraction incision predicts incisional hernia risk after nephrectomy

A midline extraction incision appears to contribute to a greater risk of incisional hernia (IH) following a minimally invasive nephrectomy, according to a study.

Stroke during pregnancy makes subsequent pregnancies high-risk

Women who have had an ischaemic stroke (IS) during a pregnancy face increased risk of complications in subsequent pregnancies, according to a study.

Premenstrual disorders harm quality of life

Premenstrual disorders, especially premenstrual dysphoric disorder, are associated with reduced quality of life in women, according to a cross-sectional study from Sweden.

ATTAIN-1: GLP-1RA pill confers weight-loss benefits in adults with obesity

In adults with obesity but without diabetes, treatment with the oral small-molecule, nonpeptide glucagon-like peptide-1 receptor agonist (GLP-1RA) orforglipron yields substantial reductions in body weight, as shown in the phase III ATTAIN-1 trial.

DOAC vs warfarin: Which agent is safer for AF patients with cirrhosis?

The use of direct oral anticoagulants (DOACs) appears to be safer than warfarin for patients with nonvalvular atrial fibrillation (AF) and liver cirrhosis (LC), suggests a study. This is particularly true to reducing the risk of major bleeding in those with Child-Pugh class A disease.